Leukemia
New findings from Edouard Herriot Hospital, Department of Hematology describe advances in leukemia
Published in Blood Weekly, May 6th, 2010
New investigation results, 'Which AML subsets benefit from leukemic cell priming during chemotherapy' Long-term analysis of the ALFA-9802 GM-CSF study,' are detailed in a study published in Cancer. According to a study from Lyon, France, "Priming with granulocytic hematopoietic growth factors may modulate cell cycle kinetics of leukemic cells and render them more susceptible to phase-specific chemotherapeutic agents. In a first report, we have shown that priming with granulocyte-macrophage colony-stimulating factor (GM-CSF) may enhance complete remission (CR) rate and event-free survival (EFS) in younger adults with acute myeloid leukemia (AML)."
"In this...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-05-06)
More Articles from Blood Weekly
- World Journal of Gastroenterology
Ischemic preconditioning alters hepatic blood supply - Affymetrix, Inc.
Affymetrix Launches DNA Copy Number Service for Difficult FFPE Samples in Cancer Research - Alpha-thalassemia
Southern Medical University publishes research in alpha-thalassemia - Anemia
New findings in anemia described from Affiliated Hospital - Anemia
New research on anemia from University of Nevada summarized - Anemia
Scientists at Indiana University publish new data on anemia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
